Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | APEX1 | P27695 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | TUBB4A | P04350 | 5/20 | 0.67 |
| ▸ | TUBB | P07437 | 5/20 | 0.67 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.67 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.67 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.67 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.67 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.67 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.67 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.67 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.67 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.67 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15535668 | 0.89 | TUBB4A (0.69) | TSHRCYP1A2CYP3A4NFKB1LMNA | |
| SCHEMBL31527689 | 0.85 | TUBB4A (0.68) | TSHRCYP1A2CYP3A4NFKB1LMNA | |
| SCHEMBL27183199 | 0.85 | TUBB4A (0.68) | TSHRCYP1A2CYP3A4NFKB1LMNA | |
| SCHEMBL29833121 | 0.85 | CYP3A4 (0.71) | TSHRCYP1A2CYP3A4NFKB1LMNA | |
| SCHEMBL901444 | 0.85 | CYP3A4 (0.71) | TSHRCYP1A2CYP3A4NFKB1LMNA | |
| SCHEMBL30045575 | 0.85 | TAAR1 (0.73) | TSHRCYP3A4NFKB1LMNAGAA | |
| SCHEMBL43681 | 0.85 | TAAR1 (0.73) | TSHRCYP3A4NFKB1LMNAGAA | |
| SCHEMBL13098004 | 0.84 | ATM (0.66) | CYP1A2CYP3A4KMT2AKDM4EALDH1A1 | |
| SCHEMBL296593 | 0.84 | ATM (0.66) | CYP1A2CYP3A4KMT2AKDM4EALDH1A1 | |
| SCHEMBL347472 | 0.84 | CYP1A2 (0.65) | TSHRCYP1A2CYP3A4NFKB1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111343993-B | Homovanillyl alcohol (HVA), HVA isomers, methods of making compositions comprising such compounds, and methods of using such compounds | 雀巢产品有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-102860999-B | 1-deoxidation-D-xylulose5-phosphoric acid reduction isomerization enzyme inhibitor and preparation method thereof | UNIV NORTHWESTERN | 2014-04-09 | — | — | CN | claimed |
| CN-102860999-A | 1-deoxidation-D-xylulose5-phosphoric acid reduction isomerization enzyme inhibitor and preparation method thereof | UNIV NORTHWESTERN | 2013-01-09 | — | — | CN | claimed |
| US-20250287976-A1 | COMPOSITIONS AND METHODS USING AT LEAST ONE OF OLEUROPEIN OR A METABOLITE THEREOF TO TREAT OR PREVENT MUSCLE FATIGUE FROM EXERCISE AND/OR FOR RESISTANCE TO MUSCLE FATIGUE FROM EXERCISE | NESTLE SA (CH) | 2025-09-18 | — | — | US | disclosed |
| US-20250228794-A1 | HOMOVANILLYL ALCOHOL (HVA), HVA ISOMER, METHODS OF MAKING COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS USING SUCH COMPOUNDS | NESTLE SA (CH) | 2025-07-17 | — | — | US | disclosed |
| CN-119013029-A | Compositions and methods for treating or preventing exercise-induced muscle fatigue and/or for combating exercise-induced muscle fatigue using at least one of oleuropein or a metabolite thereof | 雀巢产品有限公司 | 2024-11-22 | — | — | CN | disclosed |
| EP-3997086-B1 | TETRAHYDROISOQUINOLINE COMPOUNDS | ALLINKY BIOPHARMA (ES) | 2024-06-05 | — | — | EP | disclosed |
| CN-111343993-B | Homovanillyl alcohol (HVA), HVA isomers, methods of making compositions comprising such compounds, and methods of using such compounds | 雀巢产品有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-3706759-B1 | HOMOVANILLYL ALCOHOL (HVA), HVA ISOMER, METHODS OF MAKING COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS USING SUCH COMPOUNDS | NESTLE SA (CH) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023213780-A1 | COMPOSITIONS AND METHODS USING AT LEAST ONE OF OLEUROPEIN OR A METABOLITE THEREOF TO TREAT OR PREVENT MUSCLE FATIGUE FROM EXERCISE AND/OR FOR RESISTANCE TO MUSCLE FATIGUE FROM EXERCISE | Société des Produits Nestlé S.A. (CH) | 2023-11-09 | — | — | WO | disclosed |
| US-20230255238-A2 | COMPOSITIONS AND METHODS USING AT LEAST ONE OF OLEUROPEIN OR A METABOLITE THEREOF TO TREAT OR PREVENT MUSCLE FATIGUE FROM EXERCISE AND/OR FOR RESISTANCE TO MUSCLE FATIGUE FROM EXERCISE | NESTLE SA (CH) | 2023-08-17 | — | — | US | disclosed |
| WO-2002011732-A1 | NOVEL BICYCLIC AND TRICYCLIC PYRROLIDINE DERIVATIVES AS GNRH ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2002-02-14 | — | — | WO | disclosed |
| EP-0939749-A1 | PROCESS FOR THE PREPARATION OF BENZYL-ETHERS | Agro-Chemie Növenyvedöszer Gyárto Ertékesito Es Forgalmazo KFT. (HU) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998022416-A1 | PROCESS FOR THE PREPARATION OF BENZYL-ETHERS | AGRO-CHEMIE NÖVÉNYVÉDÖSZER GYÁRTÓ ÉRTÉKESITÓ ÉS FORGALMAZÓ KFT. (HU) | 1998-05-28 | — | — | WO | disclosed |
| US-5534626-A | SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES | PFIZER INC. (US) | 1996-07-09 | — | — | US | disclosed |
| US-5410046-A | Selective muscarinic receptor antagonists | PFIZER INC. (US) | 1995-04-25 | — | — | US | disclosed |
| US-5231104-A | Anticholinergic | PFIZER INC. (US) | 1993-07-27 | — | — | US | disclosed |
| EP-0350309-B1 | PIPERIDINE DERIVATIVES | Pfizer Limited (GB) | 1992-11-11 | — | — | EP | disclosed |
| US-5089505-A | Anticholinergic agents | PFIZER INC. (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0350309-A1 | Piperidine derivatives | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |